Zhimi
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Zhimi - overview
Established
2019
Location
Shanghai, -, China
Primary Industry
Healthcare IT
About
Founded in 2019 and based in Shanghai, China, Zhimi is a medical technology company that provides GxP one-stop information solutions. In 2019, the company released version 1. 0 of the key drug traceability platform. In 2023, it was acquired by Mingdu Zhiyun.
The company's main business includes PTIMP personalized treatment information management platform solutions, quality management system solutions, MES solutions for the pharmaceutical industry and computerized system verification consulting services. PTIMP personalized treatment information management platform solution includes SPIS Zhimi production identification system and SPTS Zhimi process traceability system. Its products are used in fields such as cell personalized therapy.
Current Investors
Mingdu Zhiyun
Primary Industry
Healthcare IT
Sub Industries
Consulting Services, Healthcare IT, Medical Software, Engineering Software
Website
www.zmyy.ltd
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.